Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Robert H. Carpenter"'
Publikováno v:
Geological Society of America Abstracts with Programs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::527c0272377e11063230bf1a43e80773
https://doi.org/10.1130/abs/2017se-290036
https://doi.org/10.1130/abs/2017se-290036
Publikováno v:
Cancer Gene Therapy. 11:389-396
Geriatric and cancer-afflicted patients often experience decreased quality of life with cachexia, anemia, anorexia, and decreased activity level. We have studied the possibility that a myogenic plasmid that expresses growth hormone releasing hormone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::196425ed876f2e0a1b6dbecc9d1490ea
https://doi.org/10.1038/sj.cgt.7700717
https://doi.org/10.1038/sj.cgt.7700717
Autor:
Robert H. Carpenter, Kevin A. Hahn, Kathleen K. Cummings, Glen K. King, Ruxandra Draghia-Akli
Publikováno v:
Molecular Therapy. 6:830-836
Cachexia is a common manifestation of late stage malignancy and is characterized by anemia, anorexia, muscle wasting, loss of adipose tissue, and fatigue. Although cachexia is disabling and can diminish the life expectancy of cancer patients, there a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9afbe91d2240eb7e8d34a71883664fe
https://doi.org/10.1006/mthe.2002.0807
https://doi.org/10.1006/mthe.2002.0807
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 12:345-349
We report a pilot toxicity study in healthy beagle dogs which revealed no significant adverse events for TVZ-7 given at i.v. doses up to 520 mg/kg/day. All treated dogs displayed calm behavior and maintained normal clinical laboratory values througho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67643d80d2804dcd0f9a5758ae65f0df
https://doi.org/10.1089/cbr.1997.12.345
https://doi.org/10.1089/cbr.1997.12.345
Autor:
Ruxandra Draghia-Akli, Patricia A. Brown, Deena Parghi, Amir S. Khan, Robert H. Carpenter, Kathleen K. Cummings
Publikováno v:
Technology in cancer researchtreatment. 1(5)
Electroporation has been shown to significantly increase plasmid transfer to the skeletal muscle, but this procedure is also implicated in muscle damage. We are reporting a highly efficient in vivo transfer of a plasmid formulated with poly-(L-glutam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d052a02a27448e0d74993b929d15cd17
https://pubmed.ncbi.nlm.nih.gov/12625762
https://pubmed.ncbi.nlm.nih.gov/12625762
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 12(5)
One of the zwitterion buffers that has shown significant therapeutic value in the treatment of pain due to cancer, immunologically mediated diseases, and the pain associated with these conditions is in the class of N-substituted amino-sulfonic acids
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56c5564b489bdbbea9b0e4d393b1a585
https://pubmed.ncbi.nlm.nih.gov/10851486
https://pubmed.ncbi.nlm.nih.gov/10851486
Publikováno v:
Molecular Therapy. 9:S105
Top of pageAbstract Geriatric and cancer-afflicted patients often experience decreased quality of life with cachexia, anemia, anorexia, and decreased activity level. We have studied the possibility that a myogenic plasmid that expresses growth hormon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67c8b2fcd68fbce894828a166b7e6582
https://doi.org/10.1016/j.ymthe.2004.06.230
https://doi.org/10.1016/j.ymthe.2004.06.230
Autor:
John C. Spitzer, Robert H. Carpenter
Publikováno v:
Theriogenology. 15:389-393
A 10-day treatment regime with a subcutaneous ear implant containing 3 mg of norgestomet, accompanied by an intramuscular injection of 1.5 mg norgestomet and 0.5 mg estradiol valerate (EV) on day 1 and 750 I. U. pregnant mares serum gonadotropin (PMS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab8df41b111a55e629036805df597838
https://doi.org/10.1016/0093-691x(81)90005-4
https://doi.org/10.1016/0093-691x(81)90005-4
Autor:
Robert H. Carpenter, John C. Spitzer
Publikováno v:
Theriogenology. 16(3)
Two experiments were conducted to evaluate the efficacy of a 3-mg ear implant of norgestomet, left in situ for 10 days, in conjunction with a single injection of 1.5 mg norgestomet and 0.5 mg estradiol valerate (EV) for controlling fertile estrus in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b887f44f11e7c50de760a089dbc3cec4
https://pubmed.ncbi.nlm.nih.gov/16725641
https://pubmed.ncbi.nlm.nih.gov/16725641